Quarterly report pursuant to Section 13 or 15(d)

Marketable securities held (Details Narrative)

v2.4.0.8
Marketable securities held (Details Narrative) (USD $)
Mar. 31, 2014
Marketable Securities Held Details Narrative  
Fair value of the Call Option $ 138,000
Discount for lack of marketability 605,000
Fair value of escrowed Musclepharm securities net 3,271,000
Discount on escrowed Musclepharm securities 743,000
Fair value of escrowed Musclepharm securities gross $ 4,014,000